Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have moderate to severe rheumatoid arthritis
On methotrexate but inadequately controlled
Subjects must not have active tuberculosis or an inadequately treated tuberculosis infection
Subjects must use contraception
You may not be if
Subjects who have been previously treated with adalimumab or Tofacitinib
Subjects with any current malignancy or a history of malignancy, with the exception of adequately treated or excised non metastatic basal cell or squamous cell cancer of the skin or cervical carcinoma in situ.
Subjects with specific laboratory test abnormalities
Subjects with specific types of infections
Clareo Health | An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
